Erlotinib in wild type epidermal growth factor receptor non-small cell lung cancer: A systematic review

BACKGROUND: Targeting epidermal growth factor receptors (EGFR) is an innovative approach to managing non-small cell lung cancer (NSCLC) which harbors EGFR mutation. However, the efficacy of these agents like erlotinib in patients without the mutation is not known. METHODS: This systematic review inc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jazieh, Abdul-Rahman, Al Sudairy, Reem, Abu-Shraie, Nada, Al Suwairi, Wafaa, Ferwana, Mazen, Murad, M. Hassan
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3821279/
https://ncbi.nlm.nih.gov/pubmed/24250733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1817-1737.118503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados